Phoning it in: Telehealth costs $110 less than a primary care visit

Cara Livernois | | Health Exec | Telehealth

Virtual health visits cost $110 less than conventional primary care appointments, while also reducing patient wait times and helping address the nursing shortage, according to CNBC.

Telehealth could replace doctor visits in major cities, amid a primary care phy…

To address the needs of an aging population of patients, clinicians have turned to telehealth to effectively treat patients remotely. In the article by CNBC, 98point6 CEO and co-founder Robbie Cape explains the benefits of telehealth in the coming years.

"We actually have board-certified physicians that are behind all of the artificial intelligence that we're doing. We're using artificial intelligence not to replace the doctors, but to actually augment the doctors," Cape said.

Read the full story below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Walgreens resolves $595M lawsuit over COVID testing
Congress hesitates on long-term telemedicine expansion admid advocacy push
DEA wants to permanently anchor some COVID-era prescription regulations
Telehealth diabetes management offering now part of Amazon marketplace
Amazon One Medical sued after patient prescribed inhaler dies in ER
DEA, HHS extend telehealth controlled substance prescription rule

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.